Health care provider pays $2 million to settle unnecessary drug testing claims – Food, Drugs, Healthcare, Life Sciences

[ad_1]

U.S. health care provider pays $2 million to settle allegations of unnecessary drug tests

February 04, 2022

Cozen O’Connor

To print this article, all you need to do is be registered or log in to Mondaq.com.

Nevada AG Aaron Ford and the US DOJ have reached an agreement with healthcare provider Lipshutz & Wills Medical Group, LLP d/b/a Monos Health (“Monos”) to resolve allegations that it charged wrongfully Medicaid, Medicare, and Tricare for unnecessary urine drug testing in violation of federal and state misrepresentation laws. According to the AG’s office, the case, stemming from a whistleblower complaint, involves allegations that Monos knowingly defrauded Medicaid, Medicare and Tricare by submitting false claims because it made definitive urine drug testing on the same day as presumptive urine drug testing without first assessing the individualized need for definitive testing. Monos would also have unnecessarily performed testing at higher rates when testing at a lower rate using a different billing code would have been sufficient. Under the terms of the settlement, Monos will pay approximately $2 million to settle state and federal claims against it.

The content of this article is intended to provide a general guide on the subject. Specialist advice should be sought regarding your particular situation.

POPULAR ARTICLES ON: US Food, Drugs, Healthcare, Life Sciences

[ad_2]